Raras
Buscar doenças, sintomas, genes...
Alteração de absorção mineral e transporte
ORPHA:309836CID-10 · E83CID-11 · 5C64DOENÇA RARA

Vitamina D faz parte de um grupo de secosteroides solúveis em gordura responsáveis por aumentar a absorção intestinal de cálcio, magnésio e fosfato e por muitos outros efeitos biológicos. Em humanos, os compostos mais importantes neste grupo são a vitamina D3 (também conhecida como colecalciferol) e a vitamina D2 (ergocalciferol).

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

Doença rara caracterizada por defeitos na absorção e transporte de minerais, manifestando-se com agenesia do corpo caloso, alterações na homeostase do cobre e zinco, e sintomas neurológicos e hepáticos.

Medicamentos
3 registrados
CELECOXIB, BUPROPION HYDROCHLORIDE, BUPROPION

Tem tratamento?

3 medicamentos registrados
Ver detalhes, fases e interações →
CELECOXIBBUPROPION HYDROCHLORIDEBUPROPION
🏥
SUS: Sem cobertura SUSScore: 0%
CID-10: E83
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

🧠
Neurológico
56 sintomas
🫃
Digestivo
49 sintomas
🦴
Ossos e articulações
36 sintomas
🧬
Pele e cabelo
29 sintomas
🫘
Rins
28 sintomas
💪
Músculos
24 sintomas

+ 272 sintomas em outras categorias

Características mais comuns

Agenesia do corpo caloso
Anormalidade da homeostase do cobre
Concentração sérica de testosterona diminuída
Acúmulo de cobre no fígado
Zinco sérico diminuído
Dor abdominal
592sintomas
Sem dados (592)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 592 características clínicas mais associadas, ordenadas por frequência.

Agenesia do corpo calosoAgenesis of corpus callosum
Anormalidade da homeostase do cobreAbnormality of copper homeostasis
Concentração sérica de testosterona diminuídaDecreased serum testosterone concentration
Acúmulo de cobre no fígadoCopper accumulation in liver
Zinco sérico diminuídoDecreased serum zinc

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa11
Últimos 10 anos108publicações
Pico202516 papers
Linha do tempo
20202015Hoje · 2026📈 2025Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

30 genes identificados com associação a esta condição.

SLC30A9Proton-coupled zinc antiporter SLC30A9, mitochondrialDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Mitochondrial proton-coupled zinc ion antiporter mediating the export of zinc from the mitochondria and involved in zinc homeostasis, zinc mobilization as well as mitochondrial morphology and health (PubMed:28334855, PubMed:34397090, PubMed:34433664, PubMed:35614220). In nucleus, functions as a secondary coactivator for nuclear receptors by cooperating with p160 coactivators subtypes. Plays a role in transcriptional activation of Wnt-responsive genes (By similarity)

LOCALIZAÇÃO

Mitochondrion membraneNucleusEndoplasmic reticulum

MECANISMO DE DOENÇA

Birk-Landau-Perez syndrome

An autosomal recessive syndrome characterized by early-childhood onset of different combinations of intellectual disability, muscle weakness, camptocormia, oculomotor apraxia, and nephropathy.

EXPRESSÃO TECIDUAL(Ubíquo)
Cérebro - Hemisfério cerebelar
40.2 TPM
Fibroblastos
37.3 TPM
Pituitária
35.9 TPM
Brain Frontal Cortex BA9
31.4 TPM
Nervo tibial
30.7 TPM
OUTRAS DOENÇAS (1)
psychomotor regression-oculomotor apraxia-movement disorder-nephropathy syndrome
HGNC:1329UniProt:Q6PML9
SLC11A2Natural resistance-associated macrophage protein 2Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Proton-coupled metal ion symporter operating with a proton to metal ion stoichiometry of 1:1 (PubMed:17109629, PubMed:17293870, PubMed:22736759, PubMed:25326704, PubMed:25491917). Selectively transports various divalent metal cations, in decreasing affinity: Cd(2+) > Fe(2+) > Co(2+), Mn(2+) >> Zn(2+), Ni(2+), VO(2+) (PubMed:17109629, PubMed:17293870, PubMed:22736759, PubMed:25326704, PubMed:25491917). Essential for maintenance of iron homeostasis by modulating intestinal absorption of dietary Fe

LOCALIZAÇÃO

Early endosome membraneApical cell membraneLate endosome membraneLysosome membraneCell membraneExtracellular vesicle membraneMitochondrion outer membraneGolgi apparatus, trans-Golgi network membraneRecycling endosome membrane

VIAS BIOLÓGICAS (2)
Metal ion SLC transportersIron uptake and transport
MECANISMO DE DOENÇA

Anemia, hypochromic microcytic, with iron overload 1

A hematologic disease characterized by abnormal hemoglobin content in the erythrocytes which are reduced in size. The disorder is due to an error of iron metabolism that results in high serum iron, massive hepatic iron deposition, and absence of sideroblasts and stainable bone marrow iron store. Despite adequate transferrin-iron complex, delivery of iron to the erythroid bone marrow is apparently insufficient for the demands of hemoglobin synthesis.

EXPRESSÃO TECIDUAL(Ubíquo)
Tireoide
35.2 TPM
Pulmão
32.1 TPM
Glândula salivar
29.9 TPM
Skin Sun Exposed Lower leg
23.6 TPM
Brain Spinal cord cervical c-1
23.0 TPM
OUTRAS DOENÇAS (1)
microcytic anemia with liver iron overload
HGNC:10908UniProt:P49281
SLC30A10Calcium/manganese antiporter SLC30A10Disease-causing germline mutation(s) inRestrito
FUNÇÃO

Calcium:manganese antiporter of the plasma membrane mediating the efflux of intracellular manganese coupled to an active extracellular calcium exchange (PubMed:30755481). Required for intracellular manganese homeostasis, an essential cation for the function of several enzymes, including some crucially important for the metabolism of neurotransmitters and other neuronal metabolic pathways. Manganese can also be cytotoxic and induce oxidative stress, mitochondrial dysfunction and apoptosis (PubMed

LOCALIZAÇÃO

Cell membraneGolgi apparatus membraneRecycling endosome membraneEarly endosome membrane

VIAS BIOLÓGICAS (1)
Metal ion SLC transporters
MECANISMO DE DOENÇA

Hypermanganesemia with dystonia 1

A metabolic autosomal recessive disorder characterized by dystonia, parkinsonism, extrapyramidal signs, severe hypermanganesemia, polycythemia, and chronic hepatic disease, including steatosis and cirrhosis.

EXPRESSÃO TECIDUAL(Tecido-específico)
Fígado
12.8 TPM
Brain Anterior cingulate cortex BA24
2.8 TPM
Córtex cerebral
2.7 TPM
Hipotálamo
2.6 TPM
Brain Nucleus accumbens basal ganglia
2.6 TPM
OUTRAS DOENÇAS (1)
cirrhosis - dystonia - polycythemia - hypermanganesemia syndrome
HGNC:25355UniProt:Q6XR72
HAMPHepcidinDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Liver-produced hormone that constitutes the main circulating regulator of iron absorption and distribution across tissues. Acts by promoting endocytosis and degradation of ferroportin/SLC40A1, leading to the retention of iron in iron-exporting cells and decreased flow of iron into plasma (PubMed:22682227, PubMed:29237594, PubMed:32814342). Controls the major flows of iron into plasma: absorption of dietary iron in the intestine, recycling of iron by macrophages, which phagocytose old erythrocyte

LOCALIZAÇÃO

Secreted

MECANISMO DE DOENÇA

Hemochromatosis 2B

A juvenile form of hemochromatosis, a disorder of iron metabolism with excess deposition of iron in a variety of organs leading to their failure, bronze skin pigmentation, hepatic cirrhosis, arthropathy and diabetes. The most common symptoms of juvenile hemochromatosis at presentation are hypogonadism and cardiomyopathy.

EXPRESSÃO TECIDUAL(Tecido-específico)
Fígado
597.3 TPM
Coração - Átrio
133.2 TPM
Brain Spinal cord cervical c-1
16.9 TPM
Pâncreas
4.9 TPM
Hipotálamo
4.8 TPM
OUTRAS DOENÇAS (3)
hemochromatosis type 2Bdigenic hemochromatosishemochromatosis type 2
HGNC:15598UniProt:P81172
AP1S1AP-1 complex subunit sigma-1ADisease-causing germline mutation(s) inTolerante
FUNÇÃO

Subunit of clathrin-associated adaptor protein complex 1 that plays a role in protein sorting in the late-Golgi/trans-Golgi network (TGN) and/or endosomes. The AP complexes mediate both the recruitment of clathrin to membranes and the recognition of sorting signals within the cytosolic tails of transmembrane cargo molecules

LOCALIZAÇÃO

Golgi apparatusCytoplasmic vesicle membraneMembrane, clathrin-coated pit

VIAS BIOLÓGICAS (2)
MHC class II antigen presentationLysosome Vesicle Biogenesis
MECANISMO DE DOENÇA

MEDNIK syndrome

A disorder characterized by erythematous skin lesions and hyperkeratosis, severe psychomotor retardation, peripheral neuropathy, sensorineural hearing loss, together with elevated very-long-chain fatty acids and severe congenital diarrhea.

OUTRAS DOENÇAS (1)
MEDNIK syndrome
HGNC:559UniProt:P61966
SLC40A1FerroportinDisease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Transports Fe(2+) from the inside of a cell to the outside of the cell, playing a key role for maintaining systemic iron homeostasis (PubMed:15692071, PubMed:22178646, PubMed:22682227, PubMed:24304836, PubMed:29237594, PubMed:29599243, PubMed:30247984). Transports iron from intestinal, splenic, hepatic cells, macrophages and erythrocytes into the blood to provide iron to other tissues (By similarity). Controls therefore dietary iron uptake, iron recycling by macrophages and erythrocytes, and rel

LOCALIZAÇÃO

Cell membraneBasolateral cell membrane

VIAS BIOLÓGICAS (3)
Metal ion SLC transportersIron uptake and transportDefective CP causes aceruloplasminemia (ACERULOP)
MECANISMO DE DOENÇA

Hemochromatosis 4

A disorder of iron metabolism characterized by iron overload. Excess iron is deposited in a variety of organs leading to their failure, and resulting in serious illnesses including cirrhosis, hepatomas, diabetes, cardiomyopathy, arthritis, and hypogonadotropic hypogonadism. Severe effects of the disease usually do not appear until after decades of progressive iron loading.

EXPRESSÃO TECIDUAL(Ubíquo)
Glândula adrenal
390.2 TPM
Ovário
266.1 TPM
Baço
209.0 TPM
Cervix Endocervix
117.0 TPM
Cervix Ectocervix
115.9 TPM
OUTRAS DOENÇAS (1)
hemochromatosis type 4
HGNC:10909UniProt:Q9NP59
AP1B1AP-1 complex subunit beta-1Candidate gene tested inAltamente restrito
FUNÇÃO

Subunit of clathrin-associated adaptor protein complex 1 that plays a role in protein sorting in the late-Golgi/trans-Golgi network (TGN) and/or endosomes (PubMed:31630791). The AP complexes mediate both the recruitment of clathrin to membranes and the recognition of sorting signals within the cytosolic tails of transmembrane cargo molecules

LOCALIZAÇÃO

Golgi apparatusCytoplasmic vesicle, clathrin-coated vesicle membrane

VIAS BIOLÓGICAS (2)
MHC class II antigen presentationLysosome Vesicle Biogenesis
MECANISMO DE DOENÇA

Keratitis-ichthyosis-deafness syndrome, autosomal recessive

An autosomal recessive form of keratitis-ichthyosis-deafness syndrome, a disease characterized by the association of hyperkeratotic skin lesions with vascularizing keratitis and profound sensorineural hearing loss. KIDAR patients manifest ichthyosis, failure to thrive and developmental delay in childhood, thrombocytopenia, photophobia, and progressive hearing loss. Low plasma copper and ceruloplasmin levels have been reported in some patients.

OUTRAS DOENÇAS (2)
ichthyosiform erythroderma, corneal involvement, and hearing lossMEDNIK syndrome
HGNC:554UniProt:Q10567
HJVHemojuvelinDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Acts as a bone morphogenetic protein (BMP) coreceptor (PubMed:18976966). Through enhancement of BMP signaling regulates hepcidin (HAMP) expression and regulates iron homeostasis (PubMed:18976966)

LOCALIZAÇÃO

Cell membrane

VIAS BIOLÓGICAS (1)
Netrin-1 signaling
MECANISMO DE DOENÇA

Hemochromatosis 2A

A juvenile form of hemochromatosis, a disorder of iron metabolism with excess deposition of iron in a variety of organs leading to their failure, bronze skin pigmentation, hepatic cirrhosis, arthropathy and diabetes. The most common symptoms of juvenile hemochromatosis at presentation are hypogonadism and cardiomyopathy.

VIAS REACTOME (1)
OUTRAS DOENÇAS (3)
hemochromatosis type 2Adigenic hemochromatosishemochromatosis type 2
HGNC:4887UniProt:Q6ZVN8
BMP2Bone morphogenetic protein 2Candidate gene tested inAltamente restrito
FUNÇÃO

Growth factor of the TGF-beta superfamily that plays essential roles in many developmental processes, including cardiogenesis, neurogenesis, and osteogenesis (PubMed:18436533, PubMed:24362451, PubMed:31019025). Induces cartilage and bone formation (PubMed:3201241). Initiates the canonical BMP signaling cascade by associating with type I receptor BMPR1A and type II receptor BMPR2 (PubMed:15064755, PubMed:17295905, PubMed:18436533). Once all three components are bound together in a complex at the

LOCALIZAÇÃO

Secreted

VIAS BIOLÓGICAS (3)
Regulation of RUNX2 expression and activitySignaling by BMPTranscriptional regulation by RUNX2
MECANISMO DE DOENÇA

Brachydactyly A2

A form of brachydactyly. Brachydactyly defines a group of inherited malformations characterized by shortening of the digits due to abnormal development of the phalanges and/or the metacarpals. In brachydactyly type A2 shortening of the middle phalanges is confined to the index finger and the second toe, all other digits being more or less normal. Because of a rhomboid or triangular shape of the affected middle phalanx, the end of the second finger usually deviates radially.

OUTRAS DOENÇAS (4)
short stature, facial dysmorphism, and skeletal anomalies with or without cardiac anomalies 1brachydactyly type A220p12.3 microdeletion syndromehemochromatosis type 1
HGNC:1069UniProt:P12643
CPCeruloplasminDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Multifunctional blue, copper-binding (6-7 atoms per molecule) glycoprotein. It has ferroxidase activity oxidizing Fe(2+) to Fe(3+) without releasing radical oxygen species. It is involved in iron transport across the cell membrane (PubMed:16150804). Copper ions provide a large number of enzymatic activites. Oxidizes highly toxic ferrous ions to the ferric state for further incorporation onto apo-transferrins, catalyzes Cu(+) oxidation and promotes the oxidation of biogenic amines such as norepin

LOCALIZAÇÃO

Secreted

VIAS BIOLÓGICAS (2)
Post-translational protein phosphorylationRegulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)
MECANISMO DE DOENÇA

Aceruloplasminemia

An autosomal recessive disorder of iron metabolism characterized by iron accumulation in the brain as well as visceral organs. Clinical features consist of the triad of retinal degeneration, diabetes mellitus and neurological disturbances.

OUTRAS DOENÇAS (1)
aceruloplasminemia
HGNC:2295UniProt:P00450
EGFPro-epidermal growth factorDisease-causing germline mutation(s) inTolerante
FUNÇÃO

EGF stimulates the growth of various epidermal and epithelial tissues in vivo and in vitro and of some fibroblasts in cell culture. Magnesiotropic hormone that stimulates magnesium reabsorption in the renal distal convoluted tubule via engagement of EGFR and activation of the magnesium channel TRPM6. Can induce neurite outgrowth in motoneurons of the pond snail Lymnaea stagnalis in vitro (PubMed:10964941)

LOCALIZAÇÃO

Membrane

VIAS BIOLÓGICAS (10)
PI5P, PP2A and IER3 Regulate PI3K/AKT SignalingPIP3 activates AKT signalingConstitutive Signaling by Aberrant PI3K in CancerPI3K events in ERBB2 signalingPLCG1 events in ERBB2 signaling
MECANISMO DE DOENÇA

Hypomagnesemia 4

A disorder characterized by massive renal hypomagnesemia and normal levels of serum calcium and calcium excretion. Clinical features include seizures, mild-to moderate psychomotor retardation, and brisk tendon reflexes.

EXPRESSÃO TECIDUAL(Tecido-específico)
Rim - Medula
43.6 TPM
Músculo esquelético
23.0 TPM
Pâncreas
20.6 TPM
Rim - Córtex
10.2 TPM
Glândula salivar
5.7 TPM
OUTRAS DOENÇAS (3)
renal hypomagnesemia 4adult hepatocellular carcinomaEGF-related primary hypomagnesemia with intellectual disability
HGNC:3229UniProt:P01133
ATP1A1Sodium/potassium-transporting ATPase subunit alpha-1Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

This is the catalytic component of the active enzyme, which catalyzes the hydrolysis of ATP coupled with the exchange of sodium and potassium ions across the plasma membrane. This action creates the electrochemical gradient of sodium and potassium ions, providing the energy for active transport of various nutrients (PubMed:29499166, PubMed:30388404). Could also be part of an osmosensory signaling pathway that senses body-fluid sodium levels and controls salt intake behavior as well as voluntary

LOCALIZAÇÃO

Cell membraneBasolateral cell membraneCell membrane, sarcolemmaCell projection, axonMelanosome

VIAS BIOLÓGICAS (3)
Ion homeostasisIon transport by P-type ATPasesPotential therapeutics for SARS
MECANISMO DE DOENÇA

Charcot-Marie-Tooth disease, axonal, type 2DD

A dominant axonal form of Charcot-Marie-Tooth disease, a disorder of the peripheral nervous system, characterized by progressive weakness and atrophy, initially of the peroneal muscles and later of the distal muscles of the arms. Charcot-Marie-Tooth disease is classified in two main groups on the basis of electrophysiologic properties and histopathology: primary peripheral demyelinating neuropathies (designated CMT1 when they are dominantly inherited) and primary peripheral axonal neuropathies (CMT2). Neuropathies of the CMT2 group are characterized by signs of axonal degeneration in the absence of obvious myelin alterations, normal or slightly reduced nerve conduction velocities, and progressive distal muscle weakness and atrophy.

OUTRAS DOENÇAS (2)
Charcot-Marie-tooth disease, axonal, type 2DDhypomagnesemia, seizures, and intellectual disability 2
HGNC:799UniProt:P05023
SLC39A14Metal cation symporter ZIP14Disease-causing germline mutation(s) inModerado
FUNÇÃO

Electroneutral transporter of the plasma membrane mediating the cellular uptake of the divalent metal cations zinc, manganese and iron that are important for tissue homeostasis, metabolism, development and immunity (PubMed:15642354, PubMed:27231142, PubMed:29621230). Functions as an energy-dependent symporter, transporting through the membranes an electroneutral complex composed of a divalent metal cation and two bicarbonate anions (By similarity). Beside these endogenous cellular substrates, ca

LOCALIZAÇÃO

Cell membraneApical cell membraneBasolateral cell membraneEarly endosome membraneLate endosome membraneLysosome membrane

VIAS BIOLÓGICAS (1)
Zinc influx into cells by the SLC39 gene family
MECANISMO DE DOENÇA

Hypermanganesemia with dystonia 2

A metabolic autosomal recessive disorder characterized by increased blood manganese levels, neurodegeneration, and rapidly progressive parkinsonism and dystonia. Affected individuals present with loss of developmental milestones, progressive dystonia and bulbar dysfunction in infancy or early childhood. Towards the end of the first decade, they manifest severe generalized pharmacoresistant dystonia, spasticity, limb contractures and scoliosis, and loss of independent ambulation. Cognition may be impaired, but is better preserved than motor function.

EXPRESSÃO TECIDUAL(Ubíquo)
Fígado
276.4 TPM
Pâncreas
112.8 TPM
Tireoide
101.4 TPM
Aorta
80.7 TPM
Fibroblastos
78.4 TPM
OUTRAS DOENÇAS (2)
hypermanganesemia with dystonia 2hyperostosis cranialis interna
HGNC:20858UniProt:Q15043
SLC39A4Zinc transporter ZIP4Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Selective transporter that mediates the uptake of Zn(2+) (PubMed:17202136, PubMed:22242765, PubMed:27321477, PubMed:28875161, PubMed:31164399, PubMed:31914589, PubMed:31979155, PubMed:33837739, PubMed:36473915). Plays an essential role for dietary zinc uptake from small intestine (By similarity). The Zn(2+) uniporter activity is regulated by zinc availability (PubMed:17202136, PubMed:32348750). Also exhibits polyspecific binding and transport of Cu(2+), Cd(2+) and possibly Ni(2+) but at higher c

LOCALIZAÇÃO

Cell membraneRecycling endosome membraneApical cell membrane

VIAS BIOLÓGICAS (1)
Zinc influx into cells by the SLC39 gene family
MECANISMO DE DOENÇA

Acrodermatitis enteropathica, zinc-deficiency type

A rare autosomal recessive disease caused by the inability to absorb sufficient zinc. The clinical features are growth retardation, immune-system dysfunction, alopecia, severe dermatitis, diarrhea and occasionally mental disorders.

EXPRESSÃO TECIDUAL(Ubíquo)
Intestino delgado
56.6 TPM
Cólon transverso
26.2 TPM
Rim - Córtex
22.0 TPM
Tireoide
19.6 TPM
Rim - Medula
17.8 TPM
OUTRAS DOENÇAS (1)
acrodermatitis enteropathica
HGNC:17129UniProt:Q6P5W5
RRAGDRas-related GTP-binding protein DDisease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Guanine nucleotide-binding protein that plays a crucial role in the cellular response to amino acid availability through regulation of the mTORC1 signaling cascade (PubMed:20381137, PubMed:24095279, PubMed:34607910). Forms heterodimeric Rag complexes with RagA/RRAGA or RagB/RRAGB and cycles between an inactive GTP-bound and an active GDP-bound form: RagD/RRAGD is in its active form when GDP-bound RagD/RRAGD forms a complex with GTP-bound RagA/RRAGA (or RagB/RRAGB) and in an inactive form when GT

LOCALIZAÇÃO

CytoplasmNucleusLysosome membrane

VIAS BIOLÓGICAS (7)
MacroautophagyRegulation of PTEN gene transcriptionMTOR signallingEnergy dependent regulation of mTOR by LKB1-AMPKTP53 Regulates Metabolic Genes
MECANISMO DE DOENÇA

Hypomagnesemia 7, renal, with or without dilated cardiomyopathy

An autosomal dominant renal disease characterized by hypomagnesemia, hypokalemia, salt wasting, and nephrocalcinosis. A subset of patients develop severe dilated cardiomyopathy.

EXPRESSÃO TECIDUAL(Ubíquo)
Músculo esquelético
53.2 TPM
Cérebro - Hemisfério cerebelar
48.2 TPM
Cerebelo
39.8 TPM
Linfócitos
35.5 TPM
Glândula salivar
32.9 TPM
OUTRAS DOENÇAS (2)
hypomagnesemia 7, renal, with or without dilated cardiomyopathytubular renal disease-cardiomyopathy syndrome
HGNC:19903UniProt:Q9NQL2
TRPM6Transient receptor potential cation channel subfamily M member 6Disease-causing germline mutation(s) inRestrito
FUNÇÃO

Bifunctional protein that combines an ion channel with an intrinsic kinase domain, enabling it to modulate cellular functions either by conducting ions through the pore or by phosphorylating downstream proteins via its kinase domain (PubMed:14576148, PubMed:16636202, PubMed:18258429, PubMed:18365021). Crucial for Mg(2+) homeostasis. Has an important role in epithelial Mg(2+) transport and in the active Mg(2+) absorption in the gut and kidney (PubMed:14576148). However, whether TRPM6 forms functi

LOCALIZAÇÃO

Cell membraneApical cell membraneNucleus

VIAS BIOLÓGICAS (1)
TRP channels
MECANISMO DE DOENÇA

Hypomagnesemia 1

A disorder due to a primary defect in intestinal magnesium absorption. It is characterized by low levels of serum magnesium alongside with a normal renal magnesium secretion, secondary hypocalcemia and calcinocis. Affected individuals show neurologic symptoms of hypomagnesemic hypocalcemia, including seizures and muscle spasms, during infancy. Hypocalcemia is secondary to parathyroid failure resulting from magnesium deficiency. Untreated, the disorder may be fatal or may result in neurological damage.

VIAS REACTOME (1)
EXPRESSÃO TECIDUAL(Baixa expressão)
Brain Spinal cord cervical c-1
4.5 TPM
Testículo
3.0 TPM
Cólon transverso
2.6 TPM
Sangue
2.4 TPM
Substância negra
1.7 TPM
OUTRAS DOENÇAS (1)
intestinal hypomagnesemia 1
HGNC:17995UniProt:Q9BX84
TFSerotransferrinDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Transferrins are iron binding transport proteins which can bind two Fe(3+) ions in association with the binding of an anion, usually bicarbonate. It is responsible for the transport of iron from sites of absorption and heme degradation to those of storage and utilization. Serum transferrin may also have a further role in stimulating cell proliferation (Microbial infection) Serves as an iron source for Neisseria species, which capture the protein and extract its iron for their own use (Microbial

LOCALIZAÇÃO

Secreted

VIAS BIOLÓGICAS (2)
Post-translational protein phosphorylationRegulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)
MECANISMO DE DOENÇA

Atransferrinemia

A rare autosomal recessive disorder characterized by abnormal synthesis of transferrin leading to iron overload and microcytic hypochromic anemia.

EXPRESSÃO TECIDUAL(Ubíquo)
Brain Spinal cord cervical c-1
2040.1 TPM
Fígado
1606.0 TPM
Substância negra
433.4 TPM
Hipocampo
264.0 TPM
Hipotálamo
174.7 TPM
OUTRAS DOENÇAS (1)
atransferrinemia
HGNC:11740UniProt:P02787
FTLFerritin light chainDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Stores iron in a soluble, non-toxic, readily available form. Important for iron homeostasis. Iron is taken up in the ferrous form and deposited as ferric hydroxides after oxidation. Also plays a role in delivery of iron to cells. Mediates iron uptake in capsule cells of the developing kidney (By similarity). Delivery to lysosomes by the cargo receptor NCOA4 for autophagic degradation and release or iron (PubMed:24695223)

LOCALIZAÇÃO

Cytoplasmic vesicle, autophagosomeCytoplasmAutolysosome

VIAS BIOLÓGICAS (2)
Scavenging by Class A ReceptorsNeutrophil degranulation
MECANISMO DE DOENÇA

Hyperferritinemia with or without cataract

An autosomal dominant disease characterized by elevated level of ferritin in serum and tissues, and early-onset bilateral cataract. Cataracts may be subclinical in some patients.

EXPRESSÃO TECIDUAL(Ubíquo)
Sangue
13154.6 TPM
Fibroblastos
12572.4 TPM
Pulmão
12131.1 TPM
Tecido adiposo
10012.1 TPM
Baço
9808.3 TPM
OUTRAS DOENÇAS (4)
neuroferritinopathyL-ferritin deficiencyhereditary hyperferritinemia with congenital cataractsobsolete genetic hyperferritinemia without iron overload
HGNC:3999UniProt:P02792
CLDN16Claudin-16Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Forms paracellular channels: coassembles with CLDN19 into tight junction strands with cation-selective channels through the strands, conveying epithelial permeability in a process known as paracellular tight junction permeability (PubMed:16234325, PubMed:18188451, PubMed:28028216). Involved in the maintenance of ion gradients along the nephron. In the thick ascending limb (TAL) of Henle's loop, facilitates sodium paracellular permeability from the interstitial compartment to the lumen, contribut

LOCALIZAÇÃO

Cell junction, tight junctionCell membrane

VIAS BIOLÓGICAS (1)
Tight junction interactions
MECANISMO DE DOENÇA

Hypomagnesemia 3

A progressive renal disease characterized by primary renal magnesium wasting with hypomagnesemia, hypercalciuria and nephrocalcinosis. Recurrent urinary tract infections and kidney stones are often observed. In spite of hypercalciuria, patients do not show hypocalcemia.

OUTRAS DOENÇAS (1)
renal hypomagnesemia 3
HGNC:2037UniProt:Q9Y5I7
CLDN19Claudin-19Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Forms paracellular channels: coassembles with CLDN16 into tight junction strands with cation-selective channels through the strands, conveying epithelial permeability in a process known as paracellular tight junction permeability (PubMed:18188451, PubMed:28028216). Involved in the maintenance of ion gradients along the nephron. In the thick ascending limb (TAL) of Henle's loop, facilitates sodium paracellular permeability from the interstitial compartment to the lumen, contributing to the lumen-

LOCALIZAÇÃO

Cell junction, tight junctionCell membrane

VIAS BIOLÓGICAS (1)
Tight junction interactions
MECANISMO DE DOENÇA

Hypomagnesemia 5, renal, with or without ocular involvement

A progressive renal disease characterized by primary renal magnesium wasting with hypomagnesemia, hypercalciuria and nephrocalcinosis associated with severe ocular abnormalities such as bilateral chorioretinal scars, macular colobomata, significant myopia and nystagmus. The renal phenotype is virtually undistinguishable from that of patients with HOMG3.

OUTRAS DOENÇAS (1)
renal hypomagnesemia 5 with ocular involvement
HGNC:2040UniProt:Q8N6F1
HFEHereditary hemochromatosis proteinDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Binds to transferrin receptor (TFR) and reduces its affinity for iron-loaded transferrin

LOCALIZAÇÃO

Cell membrane

VIAS BIOLÓGICAS (1)
Transferrin endocytosis and recycling
MECANISMO DE DOENÇA

Hemochromatosis 1

A disorder of iron metabolism characterized by iron overload. Excess iron is deposited in a variety of organs leading to their failure, and resulting in serious illnesses including cirrhosis, hepatomas, diabetes, cardiomyopathy, arthritis, and hypogonadotropic hypogonadism. Severe effects of the disease usually do not appear until after decades of progressive iron loading.

EXPRESSÃO TECIDUAL(Ubíquo)
Fibroblastos
15.7 TPM
Glândula adrenal
8.8 TPM
Baço
7.8 TPM
Aorta
6.6 TPM
Cervix Endocervix
6.5 TPM
OUTRAS DOENÇAS (6)
hemochromatosis type 1sporadic porphyria cutanea tardafamilial porphyria cutanea tardaobsolete symptomatic form of hemochromatosis type 1
HGNC:4886UniProt:Q30201
ATP7BCopper-transporting ATPase 2Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Copper ion transmembrane transporter involved in the export of copper out of the cells. It is involved in copper homeostasis in the liver, where it ensures the efflux of copper from hepatocytes into the bile in response to copper overload

LOCALIZAÇÃO

Golgi apparatus, trans-Golgi network membraneLate endosomeGolgi apparatus membraneCytoplasmMitochondrion

VIAS BIOLÓGICAS (1)
Ion transport by P-type ATPases
MECANISMO DE DOENÇA

Wilson disease

An autosomal recessive disorder of copper metabolism in which copper cannot be incorporated into ceruloplasmin in liver, and cannot be excreted from the liver into the bile. Copper accumulates in the liver and subsequently in the brain and kidney. The disease is characterized by neurologic manifestations and signs of cirrhosis.

OUTRAS DOENÇAS (1)
Wilson disease
HGNC:870UniProt:P35670
KCNA1Potassium voltage-gated channel subfamily A member 1Candidate gene tested inTolerante
FUNÇÃO

Voltage-gated potassium channel that mediates transmembrane potassium transport in excitable membranes, primarily in the brain and the central nervous system, but also in the kidney (PubMed:19903818, PubMed:8845167). Contributes to the regulation of the membrane potential and nerve signaling, and prevents neuronal hyperexcitability (PubMed:17156368). Forms tetrameric potassium-selective channels through which potassium ions pass in accordance with their electrochemical gradient. The channel alte

LOCALIZAÇÃO

Cell membraneMembraneCell projection, axonCytoplasmic vesiclePerikaryonEndoplasmic reticulumCell projection, dendriteCell junctionSynapsePresynaptic cell membranePresynapse

VIAS BIOLÓGICAS (1)
Voltage gated Potassium channels
MECANISMO DE DOENÇA

Episodic ataxia 1

An autosomal dominant disorder characterized by brief episodes of ataxia and dysarthria. Neurological examination during and between the attacks demonstrates spontaneous, repetitive discharges in the distal musculature (myokymia) that arise from peripheral nerve. Nystagmus is absent.

EXPRESSÃO TECIDUAL(Tecido-específico)
Cérebro - Hemisfério cerebelar
56.0 TPM
Cerebelo
42.4 TPM
Brain Frontal Cortex BA9
13.3 TPM
Brain Nucleus accumbens basal ganglia
7.8 TPM
Brain Caudate basal ganglia
7.8 TPM
OUTRAS DOENÇAS (5)
episodic ataxia type 1early-infantile DEEepisodic kinesigenic dyskinesiahereditary continuous muscle fiber activity
HGNC:6218UniProt:Q09470
PSTPIP1Proline-serine-threonine phosphatase-interacting protein 1Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Involved in regulation of the actin cytoskeleton. May regulate WAS actin-bundling activity. Bridges the interaction between ABL1 and PTPN18 leading to ABL1 dephosphorylation. May play a role as a scaffold protein between PTPN12 and WAS and allow PTPN12 to dephosphorylate WAS. Has the potential to physically couple CD2 and CD2AP to WAS. Acts downstream of CD2 and CD2AP to recruit WAS to the T-cell:APC contact site so as to promote the actin polymerization required for synapse induction during T-c

LOCALIZAÇÃO

CytoplasmCell membraneCell projection, uropodiumCytoplasm, cytoskeletonCytoplasm, perinuclear regionCell projection, lamellipodiumCleavage furrow

VIAS BIOLÓGICAS (2)
Purinergic signaling in leishmaniasis infectionThe NLRP3 inflammasome
MECANISMO DE DOENÇA

Pyogenic sterile arthritis, pyoderma gangrenosum, and acne

A rare autosomal dominant autoinflammatory disease that typically presents with recurrent sterile, erosive arthritis in childhood, occurring spontaneously or after minor trauma, occasionally resulting in significant joint destruction. By puberty, joint symptoms tend to subside and cutaneous symptoms increase. Cutaneous manifestations include pathergy, frequently with abscesses at the sites of injections, severe cystic acne, and recurrent nonhealing sterile ulcers, often diagnosed as pyoderma gangrenosum.

EXPRESSÃO TECIDUAL(Ubíquo)
Sangue
99.1 TPM
Baço
47.7 TPM
Pulmão
14.8 TPM
Aorta
11.8 TPM
Linfócitos
7.5 TPM
OUTRAS DOENÇAS (2)
pyogenic arthritis-pyoderma gangrenosum-acne syndromehyperzincemia with functional zinc depletion
HGNC:9580UniProt:O43586
FXYD2Sodium/potassium-transporting ATPase subunit gammaDisease-causing germline mutation(s) inTolerante
FUNÇÃO

May be involved in forming the receptor site for cardiac glycoside binding or may modulate the transport function of the sodium ATPase

LOCALIZAÇÃO

Membrane

VIAS BIOLÓGICAS (3)
Ion homeostasisIon transport by P-type ATPasesPotential therapeutics for SARS
MECANISMO DE DOENÇA

Hypomagnesemia 2

A disorder due to primary renal wasting of magnesium. Plasma levels of other electrolytes are normal. The only abnormality found, in addition to low magnesium levels, is lowered renal excretion of calcium resulting in hypocalciuria.

EXPRESSÃO TECIDUAL(Tecido-específico)
Rim - Medula
574.8 TPM
Rim - Córtex
299.0 TPM
Pâncreas
37.9 TPM
Glândula salivar
9.4 TPM
Ovário
5.8 TPM
OUTRAS DOENÇAS (1)
renal hypomagnesemia 2
HGNC:4026UniProt:P54710
FTH1Ferritin heavy chainDisease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Stores iron in a soluble, non-toxic, readily available form. Important for iron homeostasis. Has ferroxidase activity (PubMed:9003196). Iron is taken up in the ferrous form and deposited as ferric hydroxides after oxidation (PubMed:9003196). Also plays a role in delivery of iron to cells (By similarity). Mediates iron uptake in capsule cells of the developing kidney (By similarity). Delivery to lysosomes is mediated by the cargo receptor NCOA4 for autophagic degradation and release of iron (PubM

LOCALIZAÇÃO

CytoplasmLysosomeCytoplasmic vesicle, autophagosome

VIAS BIOLÓGICAS (2)
Scavenging by Class A ReceptorsNeutrophil degranulation
MECANISMO DE DOENÇA

Hemochromatosis 5

A disorder of iron metabolism characterized by iron overload. Excess iron is deposited in a variety of organs leading to their failure, and resulting in serious illnesses including cirrhosis, hepatomas, diabetes, cardiomyopathy, arthritis, and hypogonadotropic hypogonadism. Severe effects of the disease usually do not appear until after decades of progressive iron loading.

EXPRESSÃO TECIDUAL(Ubíquo)
Fibroblastos
4592.9 TPM
Nervo tibial
3095.0 TPM
Sangue
3042.7 TPM
Pulmão
2479.3 TPM
Tecido adiposo
2441.4 TPM
OUTRAS DOENÇAS (2)
neurodegeneration with brain iron accumulation 9hemochromatosis type 5
HGNC:3976UniProt:P02794
CNNM2Metal transporter CNNM2Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Divalent metal cation transporter. Mediates transport of divalent metal cations in an order of Mg(2+) > Co(2+) > Mn(2+) > Sr(2+) > Ba(2+) > Cu(2+) > Fe(2+) (By similarity)

LOCALIZAÇÃO

Cell membrane

MECANISMO DE DOENÇA

Hypomagnesemia 6

A renal disease characterized by severely lowered serum magnesium levels in the absence of other electrolyte disturbances. Affected individuals show an inappropriately normal urinary magnesium excretion, demonstrating a defect in tubular reabsorption. Age of clinical onset is highly variable and some affected individuals are asymptomatic.

OUTRAS DOENÇAS (3)
renal hypomagnesemia 6hypomagnesemia, seizures, and intellectual disability 1primary hypomagnesemia-generalized seizures-intellectual disability-obesity syndrome
HGNC:103UniProt:Q9H8M5
ATP7ACopper-transporting ATPase 1Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

ATP-driven copper (Cu(+)) ion pump that plays an important role in intracellular copper ion homeostasis (PubMed:10419525, PubMed:11092760, PubMed:28389643). Within a catalytic cycle, acquires Cu(+) ion from donor protein on the cytoplasmic side of the membrane and delivers it to acceptor protein on the lumenal side. The transfer of Cu(+) ion across the membrane is coupled to ATP hydrolysis and is associated with a transient phosphorylation that shifts the pump conformation from inward-facing to

LOCALIZAÇÃO

Golgi apparatus, trans-Golgi network membraneCell membraneMelanosome membraneEarly endosome membraneCell projection, axonCell projection, dendritePostsynaptic densityCytoplasm, cytosolEndoplasmic reticulum

VIAS BIOLÓGICAS (1)
Detoxification of Reactive Oxygen Species
MECANISMO DE DOENÇA

Menkes disease

An X-linked recessive disorder of copper metabolism characterized by generalized copper deficiency. MNKD results in progressive neurodegeneration and connective-tissue disturbances: focal cerebral and cerebellar degeneration, early growth retardation, peculiar hair, hypopigmentation, cutis laxa, vascular complications and death in early childhood. The clinical features result from the dysfunction of several copper-dependent enzymes. A mild form of the disease has been described, in which cerebellar ataxia and moderate developmental delay predominate.

OUTRAS DOENÇAS (4)
occipital horn syndromeX-linked distal spinal muscular atrophy type 3Menkes diseaseHirschsprung disease
HGNC:869UniProt:Q04656
TFR2Transferrin receptor protein 2Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Mediates cellular uptake of transferrin-bound iron in a non-iron dependent manner. May be involved in iron metabolism, hepatocyte function and erythrocyte differentiation

LOCALIZAÇÃO

Cell membraneCytoplasm

VIAS BIOLÓGICAS (1)
Transferrin endocytosis and recycling
MECANISMO DE DOENÇA

Hemochromatosis 3

A disorder of iron metabolism characterized by iron overload. Excess iron is deposited in a variety of organs leading to their failure, and resulting in serious illnesses including cirrhosis, hepatomas, diabetes, cardiomyopathy, arthritis, and hypogonadotropic hypogonadism. Severe effects of the disease usually do not appear until after decades of progressive iron loading.

EXPRESSÃO TECIDUAL(Tecido-específico)
Fígado
425.6 TPM
Cerebelo
15.2 TPM
Cérebro - Hemisfério cerebelar
13.5 TPM
Estômago
9.1 TPM
Córtex cerebral
9.0 TPM
OUTRAS DOENÇAS (2)
hemochromatosis type 3digenic hemochromatosis
HGNC:11762UniProt:Q9UP52
SCO2Cytochrome c oxidase assembly factor SCO2Candidate gene tested inDesconhecido
FUNÇÃO

Copper metallochaperone essential for the synthesis and maturation of cytochrome c oxidase subunit II (MT-CO2/COX2); together with SCO1, facilitates the incorporation of copper into the Cu(A) site of MT-CO2/COX2 (PubMed:15229189, PubMed:17189203, PubMed:19336478, PubMed:35750769). Could also act as a thiol-disulfide oxidoreductase to regulate the redox state of the cysteines in SCO1 during maturation of MT-CO2/COX2 (PubMed:19336478)

LOCALIZAÇÃO

Mitochondrion inner membrane

VIAS BIOLÓGICAS (2)
TP53 Regulates Metabolic GenesComplex IV assembly
MECANISMO DE DOENÇA

Mitochondrial complex IV deficiency, nuclear type 2

An autosomal recessive, severe mitochondrial disorder characterized by hypotonia, global developmental delay, hypertrophic cardiomyopathy, lactic acidosis, gliosis, and neuronal loss in basal ganglia, brainstem and spinal cord. Serum lactate is increased, and laboratory studies show decreased mitochondrial complex IV protein and activity levels in various tissues, including heart and skeletal muscle. Most patients die in infancy of cardiorespiratory failure.

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
32.4 TPM
Pulmão
32.3 TPM
Fibroblastos
29.5 TPM
Esôfago - Mucosa
28.2 TPM
Fallopian Tube
28.1 TPM
OUTRAS DOENÇAS (5)
cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 1myopia 6autosomal recessive axonal charcot-marie-tooth disease due to copper metabolism defectfatal infantile encephalocardiomyopathy
HGNC:10604UniProt:O43819

Medicamentos e terapias

CELECOXIBPhase 1

Mecanismo: Cyclooxygenase-2 inhibitor

BUPROPION HYDROCHLORIDEPhase 1

Mecanismo: Norepinephrine transporter inhibitor

BUPROPIONPhase 1

Mecanismo: Norepinephrine transporter inhibitor

Ver mais no OpenTargets

Variantes genéticas (ClinVar)

113 variantes patogênicas registradas no ClinVar.

🧬 SLC30A9: NM_006345.4(SLC30A9):c.944_946del (p.Val315del) ()
🧬 SLC30A9: NM_006345.4(SLC30A9):c.784G>C (p.Gly262Arg) ()
🧬 SLC30A9: NM_006345.4(SLC30A9):c.1663-137T>G ()
🧬 SLC30A9: NM_006345.4(SLC30A9):c.143C>A (p.Ser48Ter) ()
🧬 SLC30A9: NM_006345.4(SLC30A9):c.841-1G>A ()
Ver todas no ClinVar

Vias biológicas (Reactome)

70 vias biológicas associadas aos genes desta condição.

Metal ion SLC transporters Defective SLC11A2 causes hypochromic microcytic anemia, with iron overload 1 (AHMIO1) Iron uptake and transport Nef mediated downregulation of MHC class I complex cell surface expression MHC class II antigen presentation Lysosome Vesicle Biogenesis Golgi Associated Vesicle Biogenesis Defective SLC40A1 causes hemochromatosis 4 (HFE4) (macrophages) Defective CP causes aceruloplasminemia (ACERULOP) Defective SLC40A1 causes hemochromatosis 4 (HFE4) (duodenum) Netrin-1 signaling Signaling by BMP Molecules associated with elastic fibres Transcriptional regulation by RUNX2 Regulation of RUNX2 expression and activity Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) Post-translational protein phosphorylation Platelet degranulation Signaling by ERBB2 Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants Signaling by ERBB4 SHC1 events in ERBB2 signaling PLCG1 events in ERBB2 signaling PIP3 activates AKT signaling Signaling by EGFR GRB2 events in EGFR signaling GAB1 signalosome SHC1 events in EGFR signaling EGFR downregulation GRB2 events in ERBB2 signaling PI3K events in ERBB2 signaling EGFR interacts with phospholipase C-gamma Constitutive Signaling by Aberrant PI3K in Cancer Constitutive Signaling by EGFRvIII Inhibition of Signaling by Overexpressed EGFR RAF/MAP kinase cascade ERBB2 Regulates Cell Motility PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling ERBB2 Activates PTK6 Signaling Cargo recognition for clathrin-mediated endocytosis Clathrin-mediated endocytosis Downregulation of ERBB2 signaling Extra-nuclear estrogen signaling NOTCH3 Activation and Transmission of Signal to the Nucleus Estrogen-dependent nuclear events downstream of ESR-membrane signaling Signaling by ERBB2 KD Mutants Signaling by ERBB2 ECD mutants Ion homeostasis Ion transport by P-type ATPases Potential therapeutics for SARS Zinc influx into cells by the SLC39 gene family Defective SLC39A4 causes acrodermatitis enteropathica, zinc-deficiency type (AEZ) Macroautophagy MTOR signalling mTORC1-mediated signalling Energy dependent regulation of mTOR by LKB1-AMPK TP53 Regulates Metabolic Genes Regulation of PTEN gene transcription Amino acids regulate mTORC1 TRP channels Transferrin endocytosis and recycling Scavenging by Class A Receptors Neutrophil degranulation Tight junction interactions Voltage gated Potassium channels The NLRP3 inflammasome Purinergic signaling in leishmaniasis infection Detoxification of Reactive Oxygen Species Ion influx/efflux at host-pathogen interface Complex IV assembly

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
1Fase 13
Medicamentos catalogadosEnsaios clínicos· 3 medicamentos · 0 ensaios
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Alteração de absorção mineral e transporte

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

Pesquisa e ensaios clínicos

Nenhum ensaio clínico registrado para esta condição.

🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

🥉Melhor nível de evidência: Relato de caso
Timeline de publicações
0 papers (10 anos)
#1

Impact of bovine respiratory disease on tissue-specific regulation of Zn and vitamin a metabolism and apparent absorption and retention of trace minerals.

Journal of animal science2026 Jan 08

This study aimed to characterize trace mineral and vitamin A metabolism and redistribution during clinical and subclinical respiratory infection in beef on dairy crossbred steers (n = 29; BW = 230 ± 2.14 kg). Steers were assigned to one of four groups encompassing days -6 to -1, 0 to 5, 5 to 10, and 10 to 15 of an experimental viral-bacterial respiratory challenge. Steers were adapted to metabolism crates for 5 d prior to a 5-d total urine and fecal collection period and necropsied at the end of the period. On day 0, steers were inoculated with bovine respiratory syncytial virus strain 375 followed by an intratracheal inoculation with Mannheimia haemolytica strain D153 on day 7. A natural disease challenge occurred during the study, leading to all steers showing signs of disease at necropsy. Lung pathology scores, plasma Fe concentrations, and rectal temperatures for 5 d prior to necropsy were used to categorize animals into clinical (n = 9) and subclinical (n = 20) disease. These categories were confirmed by decreases in dry matter intake (P = 0.06) and nitrogen retention (P = 0.06) in animals with clinical disease compared to subclinical. Plasma concentrations of Zn and retinol were lesser in clinical disease (P ≤ 0.005). Conversely, liver (P = 0.02) and kidney (P = 0.06) concentrations of Zn were higher in clinical disease. This tissue sequestration occurred despite no difference in apparent Zn absorption or retention (P ≥ 0.69), providing evidence of systemic mineral redistribution. There was also no difference in the apparent absorption of Cu, Fe, and Mn (P ≥ 0.44), despite some differences in tissue concentrations. At the site of infection, expression of genes regulating vitamin A transport and metabolism (STRA6, RXRα, RBP4) increased (P ≤ 0.002) in non-lesion lung relative to diseased lung. In both lesion and non-lesion lung, clinical disease decreased RALDH2 expression relative to subclinical disease (P = 0.05). These findings demonstrate that BRD induces a coordinated redistribution of trace minerals from circulation to key tissues and alters local vitamin A metabolism in the lung. This highlights that plasma micronutrient concentrations during infection are not reflective of total body status, but rather an organized physiological response that prioritizes tissue-level demands. Bovine respiratory disease is a leading cause of morbidity and mortality in the cattle industries, but little is known about the trace mineral and vitamin A metabolism of affected animals. This study investigates trace mineral absorption and retention, and trace mineral and vitamin A metabolism within key tissues of steers experimentally infected with bovine respiratory disease. While severity of disease did not impact apparent absorption of trace minerals, we found disease shifted distribution of micronutrients in key tissues, potentially explained by differences in gene expression related to their storage and movement. Data from this study highlight the impact of disease on trace mineral and vitamin A metabolism.

#2

Excess Dietary Manganese Impairs Iron Nutrition via Modulating Duodenal Transporters in Weaned Pigs.

Veterinary sciences2025 Nov 25

Despite manganese's essential role as a cofactor for multiple enzymes, its potential to disrupt iron homeostasis when supplemented in excess remains a critical knowledge gap in swine nutrition. This study evaluated the effects of Mn (manganese)-supplemented diets on growth, hematology, mineral accumulation, digestibility, and intestinal iron transporter expression in weaned pigs. A total of 128 crossbred pigs (Duroc × Landrace × Largewhite) with an average body weight of 9.82 ± 0.15 kg were randomly allotted to four dietary treatments comprising a basal diet supplemented with 0, 20, 40, or 80 mg MnSO4 per kg diet for 28 days. Blood samples were collected from 16 weaned pigs (1 pig per pen, 4 per treatment), after which animals were euthanized for tissue sampling. No differences were observed in growth performance. However, Mn concentrations in serum, liver, heart, kidney, pancreas, and metatarsal bones increased both linearly and quadratically with increasing dietary Mn (p < 0.05), and Fe (iron) concentrations in serum, hemoglobin, liver, and metatarsal bone decreased (p < 0.05). Apparent digestibility data further revealed that Mn absorption peaked at 20 mg/kg, while Fe digestibility declined linearly with increasing Mn levels. Moreover, duodenal DMT1 (divalent metal transporter 1) mRNA expression was decreased, whereas FPN1 (ferroportin 1) was upregulated. These findings demonstrate that excessive Mn supplementation impairs dietary Fe absorption and homeostasis in weaned pigs, suggesting that the antagonism occurs at both the transcriptional and intestinal absorption levels, providing critical insights for dietary formulation in swine.

#3

The effects of copper-loaded montmorillonite on intestinal morphology, microbiota, barrier function, antioxidant capacity, and gut-related gene expression in broilers.

Poultry science2025 Oct

Intestinal health is pivotal in modern poultry production, profoundly influencing growth performance and disease resistance. This study evaluated copper-loaded montmorillonite (Cu-MMT) as a novel feed additive to enhance gut health in broilers. A 21-day experiment was conducted using 270 one-day-old Arbor Acres broilers, randomly divided to three dietary treatments: a basal diet, a group supplemented with 350 mg/kg MMT, and a group supplemented with 350 mg/kg Cu-MMT. The results revealed that dietary supplementation with Cu-MMT significantly decreased the abundance of intestinal pathogens (Salmonella, Escherichia coli, and Clostridia). Concurrently, improvements in intestinal morphology were observed with Cu-MMT supplementation, characterized by elevated villus height and a higher villus height-to-crypt depth ratio. Furthermore, it reduced serum biomarkers of intestinal permeability (diamine oxidase and D-lactic acid), while upregulating the mRNA abundance of tight junction proteins (Zonula occludens-1 and occludin) and mucin-2. Furthermore, Cu-MMT outperformed MMT alone in promoting nutrient utilization, elevating digestive enzymes (amylase, lipase, trypsin) activities, and upregulating key nutrient transporters (PepT1, Bo,+AT, ATBo,+, y+LAT2, and LAT1). The Cu-MMT supplementation significantly bolstered antioxidant defenses and mucosal immunity, as reflected by increased activities of superoxide dismutase and glutathione peroxidase (GSH-Px), reduced malondialdehyde concentrations, and increased mRNA abundance of GSH-Px and mucosal secretory immunoglobulin A. Mechanistically, the beneficial effects of Cu-MMT on antioxidant capacity were primarily mediated through the activation of the nuclear factor erythroid 2-related factor 2 signaling pathway. In conclusion, Cu-MMT enhances the growth of broilers by enhancing intestinal barrier integrity, modulating gut microbiota, augmenting intestinal antioxidant capacity and promoting intestinal digestion and absorption functions, making it a promising feed additive.

#4

Enzyme-specific casein hydrolysates enhance calcium absorption and bone mineralization: Mechanistic insights from osteoblast activation and peptide profiling.

Journal of dairy science2025 Sep

Calcium bioavailability and bone mineralization are critical for skeletal health; however, conventional calcium supplements often face limitations in absorption efficiency. This study investigates how enzyme-specific hydrolysis of CN generates bioactive peptides with distinct capacities to promote calcium absorption and bone formation. Papain-derived CN hydrolysate significantly outperformed calcium chloride in restoring bone health in osteoporotic mice, elevating serum osteocalcin levels by 1.8-fold and reducing tartrate-resistant acid phosphatase levels by 41% compared with inorganic calcium. Mechanistically, papain hydrolysates upregulated the expression of TRPV5 and TRPV6 calcium transporters in intestinal cells, thereby facilitating intestinal calcium uptake. Peptidomic profiling revealed enzyme-dependent cleavage patterns: papain preferentially targets glutamate- and lysine-rich sites (e.g., ES, EK, QS), yielding peptides such as QPKTKVIPYVRYL and RELEELNVPGEIVE, which synergistically enhance calcium chelation and osteogenic signaling. Notably, micro-computed tomography analysis confirmed that papain hydrolysates restored trabecular bone density and microarchitecture in murine femurs, outperforming inorganic calcium supplementation. These findings establish a structure-activity framework for designing enzyme-tailored CN peptides to address calcium deficiency disorders, offering a transformative strategy for the development of functional nutraceuticals. The gastrointestinal tract plays a crucial role in absorbing essential nutrients, including fats, carbohydrates, proteins, vitamins, minerals, and trace elements. Malabsorption refers to impaired nutrient absorption at any point where nutrients are absorbed, and maldigestion refers to impaired nutrient digestion within the intestinal lumen or at the intestinal brush border. Although malabsorption and maldigestion differ, digestion and absorption are interdependent, and the term “malabsorption” often refers to either process of this interdependence. Malabsorption can arise from any defect in the digestion/absorption process. These defects can result from an inherent disease of the mucosa, conditions that lead to acquired damage of the mucosa, congenital defects in the intestinal membrane transport systems, impaired absorption of specific nutrients, impaired gastrointestinal motility (decreased peristalsis and stasis), disrupted bacterial flora, infection, compromised blood flow, or compromised lymphatics. The result is either a global impairment of absorption of all nutrients or specific nutrients. Impaired nutrient absorption is often located somewhere along the small intestine, where a large surface area is provided by villi and microvilli and space within the lumen. Additional contributors to digestion and absorption include the gallbladder, pancreas, blood vessels, and lymphatics, each of which has a direct relationship with the small intestine. Digestion and absorption occur by a combination of mechanical mixing, enzyme synthesis, enzyme secretion, enzymatic activity, mucosal integrity, blood supply, intestinal motility, and the intestinal microbiome. Presenting symptoms of malabsorption syndromes overlap and include some combination of diarrhea, steatorrhea, unintentional weight loss, and developmental delay or skeletal deformities in children. Due to the various causes of malabsorption syndromes, treatment and symptom management depend on the etiology.

#5

Magnesium Balance in Chronic Kidney Disease: Mineral Metabolism, Immunosuppressive Therapies and Sodium-Glucose Cotransporter 2 Inhibitors.

International journal of molecular sciences2025 Jun 13

It is now widely recognized that maintaining magnesium (Mg) homeostasis is critical for health, especially in the context of chronic kidney disease (CKD). Patients with CKD commonly develop hyperphosphatemia and secondary hyperparathyroidism, which are controlled by therapies targeting intestinal phosphate absorption and circulating calcium levels or by modulating parathyroid calcium sensing. Notably, Mg supplementation may provide dual benefits by promoting bone formation and maintaining normal mineralization with slightly elevated serum levels. Importantly, low Mg levels are associated with mortality risk in CKD, highlighting the importance of maintaining adequate serum Mg levels in these patients. Particularly, kidney transplant (KT) patients have lower circulating Mg levels, likely due to interactions with immunosuppressive treatments. Sodium-glucose co-transporter 2 (SGLT2) inhibitors have shown survival benefits in CKD and increased serum Mg levels, suggesting that Mg regulation may contribute to these outcomes. Overall, Mg plays a key role in CKD-associated mineral and bone disorders (CKD-MBD). Thus, understanding the mechanisms underlying the alteration of Mg homeostasis in CKD could improve clinical outcomes. This review summarizes the basic and clinical studies demonstrating (1) the key actions of Mg in CKD-MBD, including secondary hyperparathyroidism and bone abnormalities; (2) the distinctive profile of KT patients for Mg homeostasis; and (3) the interaction between commonly used drugs, such as SGLT2 inhibitors or immunosuppressive treatments, and Mg metabolism, providing a broad understanding of both the key role of Mg in the context of CKD and the treatments that should be considered to manage Mg levels in CKD patients.

Publicações recentes

Ver todas no PubMed

📚 EuropePMCmostrando 108

2026

Impact of bovine respiratory disease on tissue-specific regulation of Zn and vitamin a metabolism and apparent absorption and retention of trace minerals.

Journal of animal science
2025

Excess Dietary Manganese Impairs Iron Nutrition via Modulating Duodenal Transporters in Weaned Pigs.

Veterinary sciences
2025

[Exploring the potential causes of sarcopenia in sepsis patients based on proteome sequencing].

Zhonghua wei zhong bing ji jiu yi xue
2025

[The role of dietary aluminum exposure in disturbances of micronutrient metabolism and expression of metal transporter genes].

Voprosy pitaniia
2025

The effects of copper-loaded montmorillonite on intestinal morphology, microbiota, barrier function, antioxidant capacity, and gut-related gene expression in broilers.

Poultry science
2025

Enzyme-specific casein hydrolysates enhance calcium absorption and bone mineralization: Mechanistic insights from osteoblast activation and peptide profiling.

Journal of dairy science
2025

Multiomics analyses of gut microbiota and metabolites in people living with HIV before and during SARS-COV-2 infection.

Scientific reports
2025

Impaired intestinal calcium absorption and osteopathy in ICR/Mlac-hydro mice with hypoparathyroidism and severe hydronephrosis.

Scientific reports
2025

Magnesium Balance in Chronic Kidney Disease: Mineral Metabolism, Immunosuppressive Therapies and Sodium-Glucose Cotransporter 2 Inhibitors.

International journal of molecular sciences
2025

Anticancer signal transduction pathways of selenium nanoparticles in mouse colorectal cancer model.

Biochemical and biophysical research communications
2025

Idiopathic Hypercalciuria: A Comprehensive Review of Clinical Insights and Management Strategies.

Cureus
2025

Cadmium exposure and its role in joint disease: A brief review of experimental and population-based evidence.

Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements (GMS)
2025

Maternal excess dietary phosphate intake in the periconceptional period is a potential risk for mineral disorders in offspring mice.

Scientific reports
2025

Integrated Microbiome and Metabolome Analysis Reveals Correlations Between Gut Microbiota Components and Metabolic Profiles in Mice With Mitoxantrone-Induced Cardiotoxicity.

Drug design, development and therapy
2025

Calcium-Sensing Receptor in the Thick Ascending Limb and Renal Response to Hypercalcemia.

Journal of the American Society of Nephrology : JASN
2024

Effects of Magnesium Forms on the Magnesium Balance and Jejunal Transporters in Healthy Rats.

Preventive nutrition and food science
2025

Conversion of α-linolenic acid into n-3 long-chain polyunsaturated fatty acids: bioavailability and dietary regulation.

Critical reviews in food science and nutrition
2024

Resveratrol enhances the tolerance of Malus hupehensis to potassium deficiency stress.

Frontiers in plant science
2024

Expression of Manganese Transporters ZIP8, ZIP14, and ZnT10 in Brain Barrier Tissues.

International journal of molecular sciences
2025

Selenium absorption, translocation and biotransformation in pak choi (Brassica chinensis L.) after foliar application of selenium nanoparticles.

Food chemistry
2024

Intestinal lymphangiectasia: Understanding the bigger picture.

World journal of clinical cases
2024

Hyperphosphatemia in Chronic Kidney Disease: The Search for New Treatment Paradigms and the Role of Tenapanor.

International journal of nephrology and renovascular disease
2024

Genetic causes of hypophosphatemia.

Minerva medica
2024

Size effect of mesoporous silica nanoparticles on regulating the immune effect of oral influenza split vaccine.

Colloids and surfaces. B, Biointerfaces
2024

Kidney-tonifying blood-activating decoction delays ventricular remodeling in rats with chronic heart failure by regulating gut microbiota and metabolites and p38 mitogen-activated protein kinase/p65 nuclear factor kappa-B/aquaporin-4 signaling pathway.

Journal of ethnopharmacology
2024

Multi-omics reveals that alkaline mineral water improves the respiratory health and growth performance of transported calves.

Microbiome
2024

Deciphering molecular basis of pesticide-induced recurrent pregnancy loss: insights from transcriptomics analysis.

Toxicology mechanisms and methods
2024

Hydrogel-encapsulated medium chain lipid-modified zeolite imidazole framework-90 as a promising platform for oral delivery of proteins.

Journal of controlled release : official journal of the Controlled Release Society
2024

Phosphate in Cardiovascular Disease: From New Insights Into Molecular Mechanisms to Clinical Implications.

Arteriosclerosis, thrombosis, and vascular biology
2024

Enhanced vegetable production in hydroponic systems using decontamination of closed circulating fluid.

Scientific reports
2024

Oh, My Gut! New insights on the role of the gastrointestinal tract and the gut microbiome in chronic kidney disease-mineral and bone disorder.

Current opinion in nephrology and hypertension
2024

Environmental selenium and human longevity: An ecogeochemical perspective.

Chemosphere
2023

Genetic Variants in WNT16 and PKD2L1 Locus Affect Heel Ultrasound Bone Stiffness: Analyses from the General Population and Patients Evaluated for Osteoporosis.

Calcified tissue international
2023

Difference in calcium accumulation in the fruit of two apple varieties and its relationship with vascular bundle development in the pedicel.

Plant physiology and biochemistry : PPB
2023

The Influence of Alcohol Consumption on Intestinal Nutrient Absorption: A Comprehensive Review.

Nutrients
2023

The use of data independent acquisition based proteomic analysis and machine learning to reveal potential biomarkers for autism spectrum disorder.

Journal of proteomics
2022

Acute High Dietary Phosphorus Following Low-Phosphorus Diet Acclimation Does Not Enhance Intestinal Fractional Phosphorus Absorption in Nephrectomized Male Rats.

JBMR plus
2023

Transcriptomic reveals the ferroptosis features of host response in a mouse model of Zika virus infection.

Journal of medical virology
2022

Identification of novel differentially expressed genes in type 1 diabetes mellitus complications using transcriptomic profiling of UAE patients: a multicenter study.

Scientific reports
2022

Mineral metabolism and ferroptosis in non-alcoholic fatty liver diseases.

Biochemical pharmacology
2022

Comparison of metabolic profiles in aqueous humour of Fuchs' syndrome and presumed viral-induced anterior uveitis patients.

Clinical &amp; experimental ophthalmology
2022

Intestinal Gastrin/CCKBR (Cholecystokinin B Receptor) Ameliorates Salt-Sensitive Hypertension by Inhibiting Intestinal Na+/H+ Exchanger 3 Activity Through a PKC (Protein Kinase C)-Mediated NHERF1 and NHERF2 Pathway.

Hypertension (Dallas, Tex. : 1979)
2022

EOS789, pan-phosphate transporter inhibitor, ameliorates the progression of kidney injury in anti-GBM-induced glomerulonephritis rats.

Pharmacology research &amp; perspectives
2022

[Role of calcium in health and reducing the risk of non-communicable diseases].

Voprosy pitaniia
2022

Role of Silica Nanoparticles in Abiotic and Biotic Stress Tolerance in Plants: A Review.

International journal of molecular sciences
2022

SLC4A2 Deficiency Causes a New Type of Osteopetrosis.

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research
2021

Novel Corneal Protein Biomarker Candidates Reveal Iron Metabolic Disturbance in High Myopia Eyes.

Frontiers in cell and developmental biology
2021

Influence of multistrain probiotic and iron supplementation on iron status in rats.

Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements (GMS)
2021

Advances in Mineral Nutrition Transport and Signal Transduction in Rosaceae Fruit Quality and Postharvest Storage.

Frontiers in plant science
2021

Diagnosis and management of X-linked hypophosphatemia in children and adolescent in the Gulf Cooperation Council countries.

Archives of osteoporosis
2021

Effect of Parathyroid Hormone on Intestinal Mucosal Sodium Dependent Phosphorus Transporter.

Iranian journal of kidney diseases
2021

Proteomic characteristics and identification of PM2.5-induced differentially expressed proteins in hepatocytes and c-Myc silenced hepatocytes.

Ecotoxicology and environmental safety
2020

Uremic Vascular Calcification: The Pathogenic Roles and Gastrointestinal Decontamination of Uremic Toxins.

Toxins
2021

FGF23 signalling and physiology.

Journal of molecular endocrinology
2021

Impact of aerosols on surface ozone during COVID-19 pandemic in southern India: A multi-instrumental approach from ground and satellite observations, and model simulations.

Journal of atmospheric and solar-terrestrial physics
2021

Subacute toxicity of mesoporous silica nanoparticles to the intestinal tract and the underlying mechanism.

Journal of hazardous materials
2020

The Association between Excess Body Mass and Disturbances in Somatic Mineral Levels.

International journal of molecular sciences
2021

Maternal and fetal vitamin D and their roles in mineral homeostasis and fetal bone development.

Journal of endocrinological investigation
2020

Quantitative proteomic analysis of the liver reveals antidepressant potential protein targets of Sinisan in a mouse CUMS model of depression.

Biomedicine &amp; pharmacotherapy = Biomedecine &amp; pharmacotherapie
2020

Coming out of the PiTs-novel strategies for controlling intestinal phosphate absorption in patients with CKD.

Kidney international
2020

EOS789, a novel pan-phosphate transporter inhibitor, is effective for the treatment of chronic kidney disease-mineral bone disorder.

Kidney international
2020

The international X-linked hypophosphataemia (XLH) registry (NCT03193476): rationale for and description of an international, observational study.

Orphanet journal of rare diseases
2020

Predictive Metagenomic Profiling, Urine Metabolomics, and Human Marker Gene Expression as an Integrated Approach to Study Alopecia Areata.

Frontiers in cellular and infection microbiology
2020

Lessons from rodent gastric bypass model of enteric hyperoxaluria.

Current opinion in nephrology and hypertension
2020

Zinc and Copper Enhance Cucumber Tolerance to Fusaric Acid by Mediating Its Distribution and Toxicity and Modifying the Antioxidant System.

International journal of molecular sciences
2020

Serum Metabolomics Revealed the Differential Metabolic Pathway in Calves with Severe Clinical Diarrhea Symptoms.

Animals : an open access journal from MDPI
2021

Phosphate Metabolism in Health and Disease.

Calcified tissue international
2020

Kidney Disease Progression Does Not Decrease Intestinal Phosphorus Absorption in a Rat Model of Chronic Kidney Disease-Mineral Bone Disorder.

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research
2019

Metabonomics of mice intestine in Codonopsis foetens induced apoptosis of intestine cancer cells.

Saudi journal of biological sciences
2019

Integrated Analysis of the Gene Expression Changes During Colorectal Cancer Progression by Bioinformatic Methods.

Journal of computational biology : a journal of computational molecular cell biology
2019

Mucociliary transport as a link between chronic rhinosinusitis and trace element dysbalance.

Medical hypotheses
2019

NSD2 silencing alleviates pulmonary arterial hypertension by inhibiting trehalose metabolism and autophagy.

Clinical science (London, England : 1979)
2019

A Simple Non-Invasive Approach toward Efficient Transdermal Drug Delivery Based on Biodegradable Particulate System.

ACS applied materials &amp; interfaces
2019

Limitations and Opportunities in Topical Drug Delivery: Interaction Between Silica Nanoparticles and Skin Barrier.

Current pharmaceutical design
2019

Role of αKlotho and FGF23 in regulation of type II Na-dependent phosphate co-transporters.

Pflugers Archiv : European journal of physiology
2018

Laboratory Microprobe X-Ray Fluorescence in Plant Science: Emerging Applications and Case Studies.

Frontiers in plant science
2018

Effect of dietary phosphorus intake and age on intestinal phosphorus absorption efficiency and phosphorus balance in male rats.

PloS one
2018

Intersection of Iron and Copper Metabolism in the Mammalian Intestine and Liver.

Comprehensive Physiology
2018

In vivo evidence for an interplay of FGF23/Klotho/PTH axis on the phosphate handling in renal proximal tubules.

American journal of physiology. Renal physiology
2018

Current and potential treatment options for hyperphosphatemia.

Expert opinion on drug safety
2018

Intestinal calcium transport and its regulation in thalassemia: interaction between calcium and iron metabolism.

The journal of physiological sciences : JPS
2018

Effects of dietary supplementation of arginine-silicate-inositol complex on absorption and metabolism of calcium of laying hens.

PloS one
2018

Effects of a high-sodium/low-potassium diet on renal calcium, magnesium, and phosphate handling.

American journal of physiology. Renal physiology
2017

Effect of Osteocyte-Ablation on Inorganic Phosphate Metabolism: Analysis of Bone-Kidney-Gut Axis.

Frontiers in endocrinology
2019

Renal phosphate handling and inherited disorders of phosphate reabsorption: an update.

Pediatric nephrology (Berlin, Germany)
2018

The Effect of Extended Release Niacin on Markers of Mineral Metabolism in CKD.

Clinical journal of the American Society of Nephrology : CJASN
2017

Therapeutic Effects of FGF23 c-tail Fc in a Murine Preclinical Model of X-Linked Hypophosphatemia Via the Selective Modulation of Phosphate Reabsorption.

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research
2017

Cytotoxicity, Intestinal Transport, and Bioavailability of Dispersible Iron and Zinc Supplements.

Frontiers in microbiology
2017

Desalted Duck Egg White Peptides Promote Calcium Uptake and Modulate Bone Formation in the Retinoic Acid-Induced Bone Loss Rat and Caco-2 Cell Model.

Nutrients
2016

Phosphorus Regulation in Chronic Kidney Disease.

Methodist DeBakey cardiovascular journal
2017

MYC-driven inhibition of the glutamate-cysteine ligase promotes glutathione depletion in liver cancer.

EMBO reports
2017

Physiological roles of zinc transporters: molecular and genetic importance in zinc homeostasis.

The journal of physiological sciences : JPS
2017

Microbiome Remodeling via the Montmorillonite Adsorption-Excretion Axis Prevents Obesity-related Metabolic Disorders.

EBioMedicine
2017

Expression of Cav1.3 calcium channel in the human and mouse colon: posttranscriptional inhibition by IFNγ.

American journal of physiology. Gastrointestinal and liver physiology
2017

Control of phosphate balance by the kidney and intestine.

Clinical and experimental nephrology
2016

Disorders of Iron Metabolism and Anemia in Chronic Kidney Disease.

Seminars in nephrology
2016

From Genotype to Phenotype: Nonsense Variants in SLC13A1 Are Associated with Decreased Serum Sulfate and Increased Serum Aminotransferases.

G3 (Bethesda, Md.)
2016

Acquired causes of intestinal malabsorption.

Best practice &amp; research. Clinical gastroenterology
2016

Lipids and bariatric procedures part 1 of 2: Scientific statement from the National Lipid Association, American Society for Metabolic and Bariatric Surgery, and Obesity Medicine Association: FULL REPORT.

Journal of clinical lipidology
2016

Transportome Profiling Identifies Profound Alterations in Crohn's Disease Partially Restored by Commensal Bacteria.

Journal of Crohn's &amp; colitis
2016

Selenium and its relationship with selenoprotein P and glutathione peroxidase in children and adolescents with Hashimoto's thyroiditis and hypothyroidism.

Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements (GMS)
2016

1H NMR-based metabolomics study on the physiological variations during the rat pregnancy process.

Molecular and cellular endocrinology
2015

Electron Microscopic Analysis of Surface Inorganic Substances on Oral and Combustible Tobacco Products.

Journal of analytical toxicology
2015

Modeling hypercalciuria in the genetic hypercalciuric stone-forming rat.

Current opinion in nephrology and hypertension
2015

A Drosophila model identifies a critical role for zinc in mineralization for kidney stone disease.

PloS one
2015

Polydopamine-embedded Cu(2-x)Se nanoparticles as a sensitive biosensing platform through the coupling of nanometal surface energy transfer and photo-induced electron transfer.

The Analyst
2015

Detection of quantitative trait loci for mineral content of Nelore longissimus dorsi muscle.

Genetics, selection, evolution : GSE
2015

Experimental colitis is associated with transcriptional inhibition of Na+/Ca2+ exchanger isoform 1 (NCX1) expression by interferon γ in the renal distal convoluted tubules.

The Journal of biological chemistry

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Alteração de absorção mineral e transporte.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Alteração de absorção mineral e transporte

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. Impact of bovine respiratory disease on tissue-specific regulation of Zn and vitamin a metabolism and apparent absorption and retention of trace minerals.
    Journal of animal science· 2026· PMID 41476140mais citado
  2. Excess Dietary Manganese Impairs Iron Nutrition via Modulating Duodenal Transporters in Weaned Pigs.
    Veterinary sciences· 2025· PMID 41472098mais citado
  3. The effects of copper-loaded montmorillonite on intestinal morphology, microbiota, barrier function, antioxidant capacity, and gut-related gene expression in broilers.
    Poultry science· 2025· PMID 40774173mais citado
  4. Enzyme-specific casein hydrolysates enhance calcium absorption and bone mineralization: Mechanistic insights from osteoblast activation and peptide profiling.
    Journal of dairy science· 2025· PMID 40685134mais citado
  5. Magnesium Balance in Chronic Kidney Disease: Mineral Metabolism, Immunosuppressive Therapies and Sodium-Glucose Cotransporter 2 Inhibitors.
    International journal of molecular sciences· 2025· PMID 40565121mais citado
  6. Genetic and non-genetic factors influencing phenotypic variability in neurofibromatosis type 1.
    Orphanet J Rare Dis· 2026· PMID 41987183recente
  7. Real-time breath metabolomics as catalyst for personalized lung cancer diagnostics: prospective matched case-control trial (LUCAbreath).
    Transl Lung Cancer Res· 2026· PMID 41982695recente
  8. The mutational burden in os odontoideum patients.
    Orphanet J Rare Dis· 2026· PMID 41981692recente
  9. European Reference Networks - a flagship activity of the EU in the field of rare and complex diseases: from 2017 to 2025.
    Orphanet J Rare Dis· 2026· PMID 41981625recente
  10. Clinical characteristics and long-term prognosis of anti-MDA5-positive dermatomyositis: a comparative study across age groups.
    Orphanet J Rare Dis· 2026· PMID 41965859recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:309836(Orphanet)
  2. MONDO:0017761(MONDO)
  3. GARD:21353(GARD (NIH))
  4. Variantes catalogadas(ClinVar)
  5. Busca completa no PubMed(PubMed)
  6. Q18553032(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Alteração de absorção mineral e transporte
Compêndio · Raras BR

Alteração de absorção mineral e transporte

ORPHA:309836 · MONDO:0017761
CID-10
E83 · Distúrbios do metabolismo de minerais
CID-11
Medicamentos
3 registrados
MedGen
UMLS
C0154260
Wikidata
Evidência
🥉 Relato de caso
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades